Ultrasound elastography is being proposed as a way to guide and monitor ablation therapy. Researchers say elastography could help ultrasound overcome limitations in this setting, and increase its visibility among other imaging modalities used for guidance.
Ultrasound elastography is being proposed as a way to guide and monitor ablation therapy. Researchers say elastography could help ultrasound overcome limitations in this setting, and increase its visibility among other imaging modalities used for guidance.
As the prevalence of liver cancer increases, physicians foresee a boom in utilization of radiofrequency and other thermal ablation procedures. Therefore, considerable procedural sophistication is needed. Ultrasound is one of the preferred imaging modalities for radiofrequency ablation guidance. However, the bubbling effect produced by thermal coagulation in tissue typically impairs sonographic visualization. Elastography helps overcome this problem by echoing tissue strain in the zone of necrosis, said Flemming Forsberg, Ph.D., a professor of radiology at Thomas Jefferson University in Philadelphia.
A research team led by James A. Zagzebski, Ph.D., and Tomy Varghese, ultrasound imaging experts in the medical physics department at the University of Wisconsin in Madison, recently unveiled results on an RFA-based technique called electrode displacement elastography. This method enhances lesion targeting by reducing sliding and motion of abdominal organs undergoing ablation. They presented their findings at the 2006 American Institute of Ultrasound in Medicine meeting in March.
"Elastographic ultrasound guidance should make procedures faster and you may get away with killing less tissue," Forsberg said. "There are still some lesions we don't see very well with ultrasound. But it becomes a trade-off when radiation is an issue. We are doing more and more ablation therapy these days. This means we could do more RFA with ultrasound that otherwise used to be performed with CT for guidance."
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.